However, it was reported that glycyrrhizin plays a role in inhibiting caspase 1/GSDMD and suppressing pyroptosis (Hua et al., 2019; Wang et al., 2020), indicating that it could block the occurrence of CRS in CAR T-cell treated patients. The gene discussed is GSDMD; the disease is congenital rubella syndrome.